Western blot of NR1H3 / LXR Alpha antibody.
NR1H3 / LXR Alpha Antibody (aa95-434)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunocytochemistry, Western Blot |
| Reactivity: | Bovine |
| Format: | Liquid |
$335.00each
Catalog Number: LS-C374316-100
Catalog Number: LS-C374316
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- LXR Alpha antibody LS-C374316 is an unconjugated rabbit polyclonal antibody to LXR Alpha (NR1H3) (aa95-434) from cow. It is reactive with bovine and cow. Validated for WB. Cited in 1 publication.
- Application
- ELISA, ICC, WB
- Reactivity
- Bov
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- Liver X receptor alpha | LXRA | LXR-a | Oxysterols receptor LXR-alpha | LXR alpha | NR1H3 | Lxralpha | RLD-1
- Recommended Dilution: ELISA
- 1:100-1:5000
- Recommended Dilution: IF/ICC
- 1:50-500
- Recommended Dilution: WB
- 1:50 - 1:400
- UniProt Number
- Q13133
- NCBI GenBank
- NM_005693 | NP_005684.2
- SwissProt
- Q13133
Target
- Target
- Cow NR1H3 / LXR Alpha
- Antigen Species
- Bovine
- Epitope
- The antibody is a rabbit polyclonal antibody raised against LXRa.
- Gene Name
- NR1H3
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- Recombinant LXRa (Asn95-Lys434)
- Immunogen Type
- Recombinant Protein Fragment
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
- Concentration
- 0.5 mg/mL
- Volume
- 100 Microliter
- Preservative
- Yes
- Purification Method
- Protein A Affinity
Storage & Handling
- Storage Conditions
- Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 24 months.
- Recommended Storage Buffer
- PBS
Fasting and fasting-mimicking treatment activate SIRT1/LXRa and alleviate diabetes-induced systemic and microvascular dysfunction. Sandra S Hammer, Cristiano P Vieira, Delaney McFarland, Maximilian Sandler, Yan Levitsky , Tim F Dorweiler, Todd A Lydic, Bright Asare-Bediako, Yvonne Adu-Agyeiwaah, Micheli S Sielski, Mariana Dupont, Ana Leda Longhini, Sergio Li Calzi, Dibyendu Chakraborty, Gail M Seigel, Denis A Proshlyakov , Maria B Grant, Julia V Busik. Diabetologia. 2021 Jul;;64:1674-1689. PubMed: 33770194 PMC: PMC8236268 (ava